Resistance to TRAIL Is Associated With Defects in Ceramide Signaling That Can Be Overcome by Exogenous C6-Ceramide Without Requiring Down-Regulation of Cellular FLICE Inhibitory Protein
Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-05-0086
Full Text
Open PDFAbstract
Available in full text
Date
September 1, 2005
Authors
Publisher
American Association for Cancer Research (AACR)